JP2013525493A5 - - Google Patents

Download PDF

Info

Publication number
JP2013525493A5
JP2013525493A5 JP2013509217A JP2013509217A JP2013525493A5 JP 2013525493 A5 JP2013525493 A5 JP 2013525493A5 JP 2013509217 A JP2013509217 A JP 2013509217A JP 2013509217 A JP2013509217 A JP 2013509217A JP 2013525493 A5 JP2013525493 A5 JP 2013525493A5
Authority
JP
Japan
Prior art keywords
formulation
concentration
galactomannan
present
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013509217A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013525493A (ja
JP5794744B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/035165 external-priority patent/WO2011140203A2/en
Publication of JP2013525493A publication Critical patent/JP2013525493A/ja
Publication of JP2013525493A5 publication Critical patent/JP2013525493A5/ja
Application granted granted Critical
Publication of JP5794744B2 publication Critical patent/JP5794744B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013509217A 2010-05-05 2011-05-04 安定化された眼用ガラクトマンナン処方物 Active JP5794744B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33151110P 2010-05-05 2010-05-05
US61/331,511 2010-05-05
PCT/US2011/035165 WO2011140203A2 (en) 2010-05-05 2011-05-04 Stabilized ophthalmic galactomannan formulations

Publications (3)

Publication Number Publication Date
JP2013525493A JP2013525493A (ja) 2013-06-20
JP2013525493A5 true JP2013525493A5 (enExample) 2014-05-08
JP5794744B2 JP5794744B2 (ja) 2015-10-14

Family

ID=44626461

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013509217A Active JP5794744B2 (ja) 2010-05-05 2011-05-04 安定化された眼用ガラクトマンナン処方物

Country Status (16)

Country Link
US (2) US20110275593A1 (enExample)
EP (1) EP2566447B1 (enExample)
JP (1) JP5794744B2 (enExample)
KR (2) KR20180001587A (enExample)
CN (2) CN106389325A (enExample)
AR (1) AR081015A1 (enExample)
AU (1) AU2011248129B2 (enExample)
BR (1) BR112012028308B1 (enExample)
CA (1) CA2798069C (enExample)
ES (1) ES2809304T3 (enExample)
MX (1) MX2012012826A (enExample)
NZ (1) NZ603345A (enExample)
SG (2) SG185422A1 (enExample)
TW (1) TWI606841B (enExample)
WO (1) WO2011140203A2 (enExample)
ZA (1) ZA201208199B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010011736A (es) * 2008-04-26 2011-01-21 Alcon Res Ltd Sistema polimérico de lágrimas artificiales.
TWI492769B (zh) * 2009-09-23 2015-07-21 Alcon Res Ltd 可注射的水性眼用組成物及其使用之方法
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
UA113434C2 (uk) * 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
EP3340982B1 (en) 2015-08-26 2021-12-15 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
AU2017290593A1 (en) 2016-06-27 2019-01-03 Achillion Pharmaceuticals, Inc. Quinazoline and indole compounds to treat medical disorders
US11260035B2 (en) 2016-10-12 2022-03-01 Ps Therapies Ltd Topical compositions and methods of use thereof
US11583496B2 (en) 2016-10-12 2023-02-21 PS Therapy Inc. Drug vehicle compositions and methods of use thereof
EP4241759A1 (en) * 2016-10-12 2023-09-13 PS Therapy, Inc. Artificial tear, contact lens and drug vehicle compositions and methods of use thereof
CN110603252A (zh) 2017-03-01 2019-12-20 艾其林医药公司 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物
WO2020041301A1 (en) 2018-08-20 2020-02-27 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
US11814391B2 (en) 2018-09-06 2023-11-14 Achillion Pharmaceuticals, Inc. Macrocyclic compounds for the treatment of medical disorders
WO2020081723A1 (en) 2018-10-16 2020-04-23 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
TWI757773B (zh) * 2019-06-28 2022-03-11 瑞士商愛爾康公司 眼用組成物
US20250197403A1 (en) 2020-02-20 2025-06-19 Achillion Pharmaceuticals, Inc. Heteroaryl compounds for treatment of complement factor d mediated disorders
CN116437913A (zh) 2020-09-23 2023-07-14 艾其林医药公司 用于治疗补体介导的病症的药物化合物
US20250277076A1 (en) 2024-03-04 2025-09-04 Alcon Inc. Mucoadhesive hydrophilic copolymers and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8028A (en) * 1851-04-08 Hokse-poweb
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
DE3827561C1 (enExample) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
US5505953A (en) * 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
CN100408100C (zh) * 1997-07-29 2008-08-06 阿尔康实验室公司 含半乳甘露聚糖聚合物和硼酸盐的眼用组合物
GB9808461D0 (en) * 1998-04-22 1998-06-17 Innovative Tech Ltd Solid borate-diol interaction products
US7084130B2 (en) * 2001-12-11 2006-08-01 Alcon, Inc. Intraocular irrigating solution having improved flow characteristics
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
WO2008036855A2 (en) * 2006-09-21 2008-03-27 Alcon Research, Ltd. Self-preserved aqueous pharmaceutical compositions
TWI434926B (zh) 2006-12-11 2014-04-21 Alcon Res Ltd 眼用組成物中聚氧化乙烯-聚氧化丁烯(peo-pbo)嵌段共聚物之使用
TW200904485A (en) * 2007-05-18 2009-02-01 Alcon Res Ltd Phospholipid compositions for contact lens care and preservation of pharmaceutical compositions
MX2010011736A (es) * 2008-04-26 2011-01-21 Alcon Res Ltd Sistema polimérico de lágrimas artificiales.
KR20110113199A (ko) 2009-02-05 2011-10-14 알콘 리서치, 리미티드 구아의 정제 방법

Similar Documents

Publication Publication Date Title
JP2013525493A5 (enExample)
CA2798069A1 (en) Stabilized ophthalmic galactomannan formulations
JP6130741B2 (ja) ソフトコンタクトレンズ用眼科組成物
JP7288289B2 (ja) 水性眼科組成物
WO2016042163A3 (en) Ophthalmic drug compositions
JP2018021007A5 (enExample)
JP2015514751A5 (enExample)
AR070824A1 (es) Suspensiones para inyeccion intravitrea de triamcinolona acetonido de baja viscosidad, altamente floculadas
JP2012051891A5 (enExample)
JP2016503058A5 (enExample)
JP5176132B2 (ja) 眼科用剤
JP2019142979A (ja) 水性液剤
JP2021046382A (ja) 制汗剤組成物
JP2016188259A (ja) 水性眼科組成物
JP6177594B2 (ja) 水性眼科組成物
CA3011436C (en) VANCOMYCIN-BASED FORMULATIONS
JP2014534215A5 (enExample)
JP5922505B2 (ja) グリチルリチン酸含有水性眼科組成物
KR102288699B1 (ko) 수성 의약 조성물
TW201722437A (zh) 眼科組成物
JP5897075B2 (ja) 粘膜適用組成物
JP2015518873A5 (enExample)
JP5916560B2 (ja) 粘膜適用組成物
WO2013008716A1 (ja) 水性眼科組成物